ZetrOZ Systems is Selected Among the Most Innovative Healthcare Companies in 2020
ZetrOZ earns a place on the 2020 Inaugural List of Most Innovative Companies in Healthcare, a list compiled by former Secretary of Veterans Health Administration, Dr. David Shulkin, M.D.
TRUMBULL, Conn., November 24, 2020 (Newswire.com) - ZetrOZ Systems, developers of the SAM family of ultrasound products, FDA-cleared bio regenerative medical devices supported with over 30 clinical efficacy studies, is proud to be recognized as one of the most innovative companies in healthcare, announcing its inclusion into the 2020 Inaugural List of Most Innovative Companies in Healthcare.
The 2020 listing of Most Innovative companies in healthcare includes 60 companies from 30 different categories of innovation within the medical industry. The listing was created by David Shulkin, M.D., President of Shulkin Solutions LLC and the Ninth Secretary of the US Department of Veterans Affairs. This is the first year that this list has been released.
"With a worldwide pandemic underway, we are seeing more innovation in our healthcare system than any other period in history. There never has been a more important time for our industry and this recognition is just one way of acknowledging those companies that are rising to the challenge," said Dr. Shulkin.
Globally there is increasing growth in healthcare companies. In the third quarter of 2020, there have been more than 1500 new investments in healthcare organizations totaling 21.8 billion dollars. This was an increase from second quarter investments in healthcare of just over 18 billion dollars.
As the COVID-19 pandemic continues, more people are looking towards innovative ways of diagnosing and treating disease, digital engagements to improve the patient experience, and new models of care delivery. ZetrOZ technology has gained clinical adoption as a multi-hour home-use ultrasound device to treat arthritis, back and neck pain, and amplify the body’s ability to heal naturally without surgery or medication. “The SAM ultrasound device treatment is a safe, effective and clinically proven option for millions of Americans who are unable to have an elected surgical procedure,” said Dr. George K Lewis, President and CEO of ZetrOZ Systems. “We anticipate continued rapid growth through the next decade in the chronic pain and sports medicine market for our product family of SAM devices,” said Dr. Lewis.
Read the complete 2020 Most Innovative Companies in Healthcare Report by clicking here: https://shulkinblog.com/f/the-2020-list-of-most-innovative-companies
To learn more about ZetrOZ and its SAM line of sustained acoustic medicine products, visit samrecover.com.
About ZetrOZ Systems
ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ®, sam®Sport and sam®Pro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.com and samrecover.com.
Source: ZetrOZ Systems
Categories: Healthcare and Medical News